Trial · NCT02088541
Adverse events3,390
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 3,390
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Nausea | Gastrointestinal disorders | Selinexor Approximately 55 mg/m^2 (60 to 120 mg Based on BSA) | 41 | 71 | 41 |
| other | Nausea | Gastrointestinal disorders | Selinexor 60mg (PV<5) (Equivalent to 35 mg/m^2) | 16 | 27 | 16 |
| other | Nausea | Gastrointestinal disorders | Selinexor 60mg (PV >=5) (Equivalent to 35 mg/m^2) | 68 | 115 | 68 |
| other | Nausea | Gastrointestinal disorders | Physician's Choice 1 (PV <5) | 13 | 39 | 13 |
| other | Nausea | Gastrointestinal disorders | Physician's Choice 2 (PV >=5) | 8 | 45 | 8 |
| other | Diarrhoea | Gastrointestinal disorders | Selinexor Approximately 55 mg/m^2 (60 to 120 mg Based on BSA) | 17 | 71 | 17 |
| other | Diarrhoea | Gastrointestinal disorders | Selinexor 60mg (PV<5) (Equivalent to 35 mg/m^2) | 13 | 27 | 13 |
| other | Diarrhoea | Gastrointestinal disorders | Selinexor 60mg (PV >=5) (Equivalent to 35 mg/m^2) | 41 | 115 | 41 |
| other | Diarrhoea | Gastrointestinal disorders | Physician's Choice 1 (PV <5) | 8 | 39 | 8 |
| other | Diarrhoea | Gastrointestinal disorders | Physician's Choice 2 (PV >=5) | 6 | 45 | 6 |
| other | Constipation | Gastrointestinal disorders | Selinexor Approximately 55 mg/m^2 (60 to 120 mg Based on BSA) | 20 | 71 | 20 |
| other | Constipation | Gastrointestinal disorders | Selinexor 60mg (PV<5) (Equivalent to 35 mg/m^2) | 8 | 27 | 8 |
| other | Constipation | Gastrointestinal disorders | Selinexor 60mg (PV >=5) (Equivalent to 35 mg/m^2) | 25 | 115 | 25 |
| other | Constipation | Gastrointestinal disorders | Physician's Choice 1 (PV <5) | 16 | 39 | 16 |
| other | Constipation | Gastrointestinal disorders | Physician's Choice 2 (PV >=5) | 15 | 45 | 15 |
| other | Vomiting | Gastrointestinal disorders | Selinexor Approximately 55 mg/m^2 (60 to 120 mg Based on BSA) | 19 | 71 | 19 |
| other | Vomiting | Gastrointestinal disorders | Selinexor 60mg (PV<5) (Equivalent to 35 mg/m^2) | 10 | 27 | 10 |
| other | Vomiting | Gastrointestinal disorders | Selinexor 60mg (PV >=5) (Equivalent to 35 mg/m^2) | 30 | 115 | 30 |
| other | Vomiting | Gastrointestinal disorders | Physician's Choice 1 (PV <5) | 7 | 39 | 7 |
| other | Vomiting | Gastrointestinal disorders | Physician's Choice 2 (PV >=5) | 6 | 45 | 6 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02088541/events